Navigation Links
Osteotech's Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Date:4/25/2008

EATONTOWN, N.J., April 25 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic solutions for regenerative medicine, announced today that the United States Food and Drug Administration ("FDA") has cleared its 510(k) submission for the Plexur P(TM) Biocomposite for use in spinal applications as a bone void filler and as a bone graft extender. Previously, Osteotech received FDA clearance for Plexur P(TM) for use in filling bony voids of the pelvis and extremities.

Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer, stated, "We are very pleased to receive FDA clearance for the use of our Plexur P(TM) product in the spine. We continue to receive many favorable comments from orthopedic surgeons about the efficacy of Plexur P(TM) and we will immediately offer our Plexur P(TM) product to spine surgeons supported by the clinical information and experience we have gained over the last year. Our proprietary Plexur(R) Technology continues to be one of the keys to our product pipeline and future growth initiatives."

To date, the Plexur P(TM) Biocomposite has been used by a variety of surgeons in tibial plateau fractures, tibial osteotomies and a variety of foot and ankle procedures, and can now be used in the spine. Our Plexur P(TM) product can be combined with our proprietary Grafton(R) DBM, local bone or our new Kinesis(TM) BMAC(TM) cellular system. Plexur P(TM) is available as granules, cylinders, blocks, wedges and sheets. For more information about the Plexur P(TM) Biocomposite, please go to our websites at http://www.plexur.com or http://www.osteotech.com.

The
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
2. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
3. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
8. IsoTis Receives FDA Clearance for Accell Family of Products
9. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
10. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
11. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...RORA, Ontario, Nov. 6 He...: HXBPF) today announced that John Docherty, presi...Merriman Curhan Ford,s 6th annual Investor Summit ...el in New York City. Mr. Docherty will provide an...ment programs L-DOS47 and Topical Interferon Alpha...
(Date:11/6/2009)...RING VALLEY, Calif., Nov. 6 Calbio...d a Small Business Innovative Research (SBIR) Phas... Material command. Under terms of the agreement, C...ASRs) for the diagnosis of Dengue virus. ,, ...presents a major threat to military forces deploye...
(Date:11/5/2009)...NSPORTATION -- Gone hybrid . . . , Fuel econom...are now posted at the www.fueleconomy.gov web si...and maintains for the U.S. Department of Energy an...f the top 10 vehicles on the best fuel economy lis...1 MPG city; 48 highway). "This list proves that hy...
(Date:11/5/2009)...N DIEGO, Nov. 5 Imagenet...ay that William Spencer, President and CEO of Imag...the 2nd annual LD MICRO Conference on Thursday, De...Los Angeles. ,, About LD MICRO ,, LD MICRO i...s on finding undervalued companies in the micro-ca...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...GA, ON, Oct. 11 /PRNewswire-FirstCall/ - YM BioSci...logy company that identifies, develops,and commerc...wide, today,advised that its Annual Meeting of Sha...t 4:00pm at the Gallery of the TSX Broadcast & Con...t West, Toronto, Ontario. The items for considera...
... Oppose Proposal to Kill Human Embryos for Researc...ference President and Chief Executive Officer Sist...atement today regarding the formation of the,ballo...In order to protect human life at its most vulnera...ated, that seeks to clone and/or kill,human embryo...
...zerland, October 11 The young Swiss biotech,enter... Michel Klein, one,of the world,s most renowned va...ice President of Science & Technology of the Avent...ship of the scientific sector of,vaccine developme...as,access to an outstanding network across one of ...
Other Biology Technology:YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 2YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 3Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC 2
(Date:11/9/2009)... a wet ethanol production method that begins by so...lts in more gallons of ethanol and more usable co-...or their buck by about 20 percent. , "The conve... but other than distillers dried grains with solub...niversity of Illinois Agricultural Engineer Esha K...
(Date:11/9/2009)... Ala. The U.S. Department of Energy (DOE) has ann... Alabama at Birmingham (UAB) School of Engineering... gas emissions through the capture and permanent s...CO2). The project is in collaboration with Souther... Funded by the DOE through the 2009 American Reco...
(Date:11/9/2009)...nce of butterfly wings has inspired a 3.2m, three-...ovation in the fields of security, energy and the ...ional technology company QinetiQ have just signed ...es based on groundbreaking physical sciences resea...icists from the University of Exeter and QinetiQ w...
Breaking Biology News(10 mins):Wet ethanol production process yields more ethanol and more co-products 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Cyberonics to Present at UBS Global Life Sciences Conference 56756 1Cyberonics to Present at UBS Global Life Sciences Conference 56756 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 1Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 3Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 4Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection 56753 1Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection 56753 2Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection 56753 3
...ions will converge in Taipei amid spiralling inter... others beginning to realize potential application...and food safety to disease prevention and better e...geoning three-year-old scientific field could, amo...mber out of global markets, slow the spread of inv...
...ield of HIV research through his rational approach...n HIV vaccine. His method is based on gaining an ...ul antibodies generated to date, and the sites on ...hat will be essential to designing improvements to... published an extensive number of papers, four of ...
... 2007 American Society for Microbiology (ASM) ICAA... Company, Inc., U.S. Human Health, will be present...ant Professor in Pediatrics, Division of Pulmonary...al Center, Seattle, Washington. Dr. Hoffman is be...ology and infectious disease. , Dr. Hoffman has...
Other Biology News:Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 2Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 3Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 4Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 5Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 6Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 7Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 8
...gands\n\nReceptor-related research has long been e...abeled ligands selected to keep pace with new disc...ts and services for receptor research and drug dis...igands. If you do not find exactly what you need, ...
...ve and specific detection of microRNAs (miRNAs) by...ave high binding affinity and discrimination, enab...s. Due to the high binding affinity of the miRCURY... needed compared to traditional probes. Furthermor...
Rabbit Anti-Mouse Vitronectin Polyclonal Antibody, Unconjugated from Abcam
...methylation is an irreversible post translational ...o protein activity. At least three types of PRMT e...ese enzymes have been shown to have essential regu... several fundamental areas. These protein include ...
Biology Products: